Evaluating the risk of mild serotonin syndrome in primary care: a retrospective case series of patients with treatment-resistant depression

This study highlights the need for careful monitoring of serotonin syndrome in patients with treatment-resistant depression, especially in the case of polypharmacy. Early recognition of symptoms by primary care providers and close management ensure patient safety through proper medication management and education.